Qingbao Guo | Neuroscience | Outstanding Scientist Award

Posted on by Forensic Scientist

Prof. Qingbao Guo | Neuroscience | Outstanding Scientist Award

Xi’an No.9 Hospital | China

Prof. Qingbao Guo is a highly accomplished Associate Chief Physician in the Department of Neurosurgery at the Second Affiliated Hospital of the Air Force Medical University (formerly Tangdu Hospital), China. He specializes in cerebrovascular disorders, brain tumors, and functional neurosurgery, and is recognized for his excellence in the diagnosis and treatment of moyamoya disease and other complex neurological conditions.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  1. Extensive Clinical Experience:

    • Over 20 years of progressive clinical practice in neurosurgery, including leadership as Associate Chief Physician at a top-tier military hospital.

    • Strong surgical expertise in cerebrovascular diseases, brain tumors, and functional neurosurgery, which are critical areas in modern neurosurgical practice.

  2. Academic Qualifications & Research:

    • A recent Ph.D. in Neurosurgery (2021–2024) focused on moyamoya disease (MMD)—a rare but significant cerebrovascular disorder.

    • Earlier Master’s-level research on peripheral vascular diseases, showing continuity in vascular-focused research.

    • Mentorship under established experts (Professors Lian Duan and Yanzheng He), enhancing academic rigor.

  3. Contribution to National Defense Health System:

    • His long-term service in military medical institutions (Air Force Medical University) underscores contributions to military medicine, a high-impact field with national importance.

  4. Interdisciplinary Relevance:

    • His work bridges clinical practice and surgical innovation, especially in the surgical management of complex neurological diseases, offering translational value to both academic and applied medicine.

🎓 Education

Prof. Qingbao Guo began his academic journey with a Bachelor’s degree in Clinical Medicine from Yan’an University (1999–2004). He furthered his specialization with a Master’s degree in Surgery (2008–2011) from Southwest Medical University, under the supervision of Prof. Yanzheng He, where he focused on clinical approaches to peripheral vascular diseases. Most recently, he earned his Ph.D. in Neurosurgery (2021–2024) from the Chinese PLA Medical School, mentored by Prof. Lian Duan, with research concentrating on the pathogenesis and surgical management of moyamoya disease.

💼 Professional Experience

Prof. Qingbao Guo has an extensive and progressive professional background in neurosurgery. He is currently serving as an Associate Chief Physician at Tangdu Hospital since September 2012, where he has amassed advanced surgical experience in managing brain tumors, vascular pathologies, and functional neurosurgical disorders. Prior to this, he was an Attending Physician at the First Affiliated Hospital of Southwest Medical University (July 2011 – August 2012), where he handled numerous vascular cases. His medical career began as a Resident Physician at Shaanxi Sengong Hospital (July 2004 – August 2008).

🔬 Research Interests On Neuroscience

Prof. Qingbao Guo’s research focuses on the pathophysiology and surgical treatment of cerebrovascular diseases, particularly moyamoya disease, a rare but serious condition affecting intracranial arteries. He is also interested in neuro-oncology, vascular neurosurgery, and advancements in functional neurosurgical procedures, with a vision to bridge translational neuroscience and surgical innovation.

🏆 Awards & Nominations

Prof. Qingbao Guo has been acknowledged for his clinical excellence and academic contribution through multiple hospital-level and regional honors. He is a nominee for the [Insert Award Name Here, e.g., “Outstanding Neurosurgeon Researcher Award 2025”] in recognition of his pioneering work in moyamoya disease surgical treatment and his consistent commitment to patient-centered research and education.

📚 Publications

🔬 Genetic Associations and Polymorphisms

  1. MTHFR Polymorphism and EDAS-induced Collateral Formation

    • [DOI: 10.3171/2024.1.JNS232121]
      Highlights the genetic influence (MTHFR) on surgical angiogenesis success post-EDAS in MMD patients.

  2. RNF213 p.R4810K Variant and Unfavorable Outcomes in Pediatric EDAS

    • [DOI: 10.1155/2024/1844190]
      Strong linkage of the RNF213 mutation with poor long-term outcomes, particularly relevant in East Asian populations.

🧪 Biomarker and Multi-Omics Studies

  1. Proteomic & Metabolomic Profiles in Pediatric MMD

    • [DOI: 10.2147/JIR.S471538]
      Identifies core disrupted pathways, potentially pointing toward new diagnostic or therapeutic targets.

  2. Complement C3 Expression & Postoperative Vasculopathy

    • [DOI: 10.2147/JIR.S451538]
      Suggests inflammatory markers like C3 as predictors of vascular changes post-intervention.

🧠 Neuroimaging and Risk Stratification

  1. MRI Vessel Wall Enhancement and MMD Outcomes

    • [DOI: 10.1007/S00330-023-10535-0]
      High-resolution MRI features were linked to clinical risk, potentially informing preoperative planning.

  2. Nomograms for Predicting Rebleeding and Outcomes

    • [DOI: 10.3171/2024.2.JNS232744]
      Well-validated clinical tools that integrate genetics and clinical features for long-term prognosis.

🧬 Pathophysiology and Comorbid Disease Connections

  1. Transcriptomics in MMD and SLE Crosstalk

    • [DOI: 10.3389/FIMMU.2024.1456392]
      A novel systems biology approach to uncover common pathways between MMD and autoimmune diseases like SLE.

  2. ZEB2 and Brain Microvascular Dysfunction Post-ICH

    • [DOI: 10.1080/15384101.2021.1959702]
      Delves into molecular mechanisms of endothelial dysfunction, bridging stroke and hemorrhage pathology.

📉 Risk Factors in Pediatric and Elderly Cohorts

  1. Preoperative Infarction & Pediatric Risk Factors

    • [DOI: 10.1007/S12975-023-01167-Z]
      Targeted focus on predictive markers in vulnerable pediatric populations.

  2. Outcomes in Elderly Post-Conservative vs. EDAS Treatment

  • [DOI: 10.3171/2023.7.JNS231060]
    Offers insights into age-specific management strategies and long-term care plans.

🔚 Conclusion

Prof. Qingbao Guo stands out as a dedicated neurosurgeon, educator, and researcher, committed to transforming patient outcomes through clinical expertise and scientific inquiry. His extensive training, hands-on experience, and impactful research make him a compelling candidate for any award celebrating excellence in medical and surgical innovation.

Chunxiao Wu | Neuroscience | Best Researcher Award

Posted on by Forensic Scientist

Dr. Chunxiao Wu | Neuroscience | Best Researcher Award

Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine | China

Dr. Chunxiao Wu (吴春晓) is a dedicated neuroscientist and clinician with a robust background in traditional Chinese medicine and modern neurological treatment. Currently serving as an Associate Professor at Guangzhou University of Chinese Medicine and a Neurology Doctor at Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, she is passionate about merging acupuncture-based therapies with scientific rigor to address complex neurological disorders like stroke and Parkinson’s disease. Her work is grounded in both clinical excellence and pioneering research.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Strong Academic Background and Career Progression

    • Dr. Wu has demonstrated consistent academic growth—from a Bachelor’s in Traditional Chinese Medicine to a PhD in Acupuncture, and now holds a position as Associate Professor.

    • Her dual role as a practicing Neurology Doctor and academic gives her research practical relevance and clinical depth.

  • Specialized and Impactful Research Area

    • Her focus on electroacupuncture for ischemic stroke and neurodegenerative disorders (e.g., Parkinson’s Disease) is both niche and highly relevant in today’s integrative medical approaches.

    • Contributions to identifying mechanisms like the NCOA4-FTH1 signaling pathway in ferroptosis add originality and depth.

  • Consistent and High-Quality Publications

    • Over 13 SCI-indexed publications, many in Q1/Q2 journals like Journal of Affective Disorders and Frontiers in Aging Neuroscience.

    • Her studies combine traditional Chinese techniques with modern bioinformatics, clinical trials, and neurochemical investigations, which enhances their scientific value.

  • Strong Research Funding Track Record

    • Principal investigator of two major national-level funded projects (NSFC and China Postdoctoral Foundation).

    • Participation in four additional NSFC projects, showing sustained involvement in collaborative and competitive research.

🎓 Education

Dr. Wu’s academic journey is marked by her deep commitment to the healing arts and medical science. She earned her Bachelor’s degree in Traditional Chinese Medicine (2009–2014) and Master’s in Acupuncture (2014–2017) from Southern Medical University. Her thirst for innovation led her to pursue a PhD in Acupuncture from Guangzhou University of Chinese Medicine (2017–2020), where she specialized in the neurological mechanisms of acupuncture therapy.

🧪 Experience

With over a decade of experience in clinical practice and scientific research, Dr. Wu has consistently advanced in her career. She began as a Postdoctoral Researcher (2020–2022) at Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, delving into electroacupuncture’s effects on ischemic stroke. Since 2022, she has been serving as a Neurology Doctor at the same hospital, and in 2023, she was appointed Associate Professor at Guangzhou University of Chinese Medicine.

🔬 Research Interests On Neuroscience

Dr. Wu’s research sits at the intersection of electroacupuncture, neurodegeneration, ischemic stroke, and ferroptosis, with a focus on molecular mechanisms such as the NCOA4-FTH1 signaling pathway and super-enhancer regulation. She applies bioinformatics and mixed-treatment comparison analyses to optimize non-pharmacological therapies for Parkinson’s disease and stroke rehabilitation.

🏆 Awards

In recognition of her significant contributions to acupuncture science and neurological rehabilitation, Dr. Wu has received:

  • 🥈 Second Prize – Science and Technology Progress Award, Chinese Society of Ethnographic Medicine

  • 🥈 Second Prize – Science and Technology Award, Guangdong Acupuncture Society

📚 Publications

Dr. Wu is a prolific author with numerous peer-reviewed publications. Her work has been widely cited in the field of integrative neurology:

  • Investigation of Ferroptosis Mechanisms in Ischemic Stroke Treated with Electroacupuncture: Focusing on the NCOA4-FTH1 Signaling Pathway​

    • Authors: Chunxiao Wu, Zhen Xu, Qian Wang, Hong Guo, Xiang He, Yujie Lin, Li Li, Ling Feng, Qian Li, Chunzhi Tang​

    • Publication Year: 2025​

  • Bioinformatics Analysis of Electroacupuncture Treatment for Ischemic Stroke: Exploring Transcriptional Regulatory Mechanisms Mediated by Super-enhancers​

    • Authors: Chunxiao Wu, Qian Wang, Zhen Xu, Cheng Deng, Chunzhi Tang​

    • Publication Year: 2025​

  • Development, Validation, and Visualization of a Novel Nomogram to Predict Depression Risk in Patients with Stroke​

    • Authors: Chunxiao Wu, Shuang Zhu, Qian Wang, Yujie Xu, Xia Mo, Wei Xu, Zhen Xu​

    • Publication Year: 2024​

  • Development, Validation, and Visualization of a Novel Nomogram to Predict Stroke Risk in Patients​

    • Authors: Chunxiao Wu, Zhen Xu, Qian Wang, Shuang Zhu, Min Li, Chunzhi Tang​

    • Publication Year: 2023​

  • Moxibustion Treatment for Parkinson’s Disease: Study Protocol for a Randomized Controlled Trial​

    • Authors: Chunxiao Wu, Lijun Zhao, Yajing Guo, Xue Hao, Yufei Fan, Peng Wu, Jian Han, Qian Li, Xue Wang, Qian Wang, Xia Luo, Ming Zhu​

    • Publication Year: 2023​

  • The Comparative Efficacy of Non-ergot Dopamine Agonist and Potential Risk Factors for Motor Complications and Side Effects from NEDA Use in Early Parkinson’s Disease: Evidence from Clinical Trials​

    • Authors: Chunxiao Wu, Hong Guo, Yujie Xu, Li Li, Xia Li, Chunzhi Tang, Dongsheng Chen, Ming Zhu​

    • Publication Year: 2022​

  • Effects of Aerobic Exercise and Mind-Body Exercise in Parkinson’s Disease: A Mixed-Treatment Comparison Analysis​

    • Authors: Chunxiao Wu, Yujie Xu, Hong Guo, Chunzhi Tang, Dongsheng Chen, Ming Zhu​

    • Publication Year: 2021​

  • Integrated Bioinformatics Analysis of Potential mRNA and miRNA Regulatory Networks in Mice with Ischemic Stroke Treated by Electroacupuncture​

    • Authors: Chunxiao Wu, Lijun Zhao, Xia Li, Yujie Xu, Hong Guo, Zhen Huang, Qian Wang, Hong Liu, Dongsheng Chen, Ming Zhu​

    • Publication Year: 2021​

  • Reply to: Qigong as a Promising Mind-Body Exercise for Cognitive Functioning​

    • Authors: Chunxiao Wu, Chunzhi Tang​

    • Publication Year: 2019​

  • Effects of Mind-Body Exercises on Cognitive Function in Older Adults: A Meta-Analysis​

    • Authors: Chunxiao Wu, Qiang Yi, Xia Zheng, Shoubao Cui, Bing Chen, Lijuan Lu, Chunzhi Tang

    • Publication Year: 2019

🎯 Conclusion

Dr. Chunxiao Wu is a shining example of integrative medical excellence, combining traditional acupuncture techniques with modern neurological insights. Her passion for research, commitment to patient care, and remarkable academic output mark her as an exceptional candidate for any prestigious research award. Her future continues to hold promise as she advances the science of mind-body medicine with impactful clinical research.

Tiziana Casoli | Neuroscience | Best Researcher Award

Posted on by Forensic Scientist

Dr. Tiziana Casoli | Neuroscience | Best Researcher Award

Senior Researcher | IRCCS INRCA | Italy

Dr. Tiziana Casoli is a Senior Researcher at IRCCS INRCA, specializing in Applied Genetics. Since 1992, she has been actively engaged in research at the Center for Neurobiology of Aging in Ancona, Italy. Her work focuses on identifying and evaluating physiological and pathological biomarkers of the aging nervous system. She has contributed to over 100 indexed publications and participated in numerous research projects as both Principal Investigator and afferent researcher. Casoli is also a proud member of the Italian Society of Geriatrics and Gerontology (SIGG) and the European Platform of Women Scientists (EPWS).

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Research Experience: Over three decades of dedicated research in neurobiology, focusing on aging, Alzheimer’s, and Parkinson’s disease.
  • Notable Contributions: Significant contributions to understanding synaptic plasticity, mitochondrial dysfunction, and the identification of biomarkers in neurodegenerative diseases.
  • Publications and Citation Impact: 104 indexed papers and a citation index of 25, demonstrating influence in the field.
  • Leadership in Research Projects: Involvement in several high-impact projects as Principal Investigator (PI) and team member.
  • Professional Recognition: Active member of SIGG and EPWS, reflecting engagement in scholarly communities.

Education 🎓

  • Specialization in Applied Genetics, University of Bologna, Italy.

Experience 💼

  • Senior Researcher, IRCCS INRCA, Center for Neurobiology of Aging, Ancona, Italy (1992 – Present).
  • Principal Investigator and collaborator in various public and private research projects.

Research Interests On Neuroscience🔬

  • Neurobiology of Aging
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Biomarkers
  • Mitochondria

Awards 🏆

  • Member of the Italian Society of Geriatrics and Gerontology (SIGG).
  • Member of the European Platform of Women Scientists (EPWS).

Publications 📄

  1. Title: Late-onset major depressive disorder: exploring the therapeutic potential of enhancing cerebral brain-derived neurotrophic factor expression through targeted microRNA delivery

    • Authors: Giovanni Lai, Marco Malavolta, Serena Marcozzi, Giorgia Bigossi, Maria Elisa Giuliani, Tiziana Casoli, Marta Balietti
    • Year: 2024

  2. Title: Analysis of mitochondrial DNA allelic changes in Parkinson’s disease: a preliminary study

    • Authors: Tiziana Casoli, Rosamaria Lisa, Paolo Fabbietti, Fiorenzo Conti
    • Year: 2020

  3. Title: Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer’s disease

    • Authors: Tiziana Casoli, Susy Paolini, Paolo Fabbietti, Patrizia Fattoretti, Lucia Paciaroni, Katia Fabi, Beatrice Gobbi, Roberta Galeazzi, Roberto Rossi, Fabrizia Lattanzio et al.
    • Year: 2019

  4. Title: My Mind Project: the effects of cognitive training for elderly—the study protocol of a prospective randomized intervention study

    • Authors: Giuli, C.; Fattoretti, P.; Gagliardi, C.; Mocchegiani, E.; Venarucci, D.; Balietti, M.; Casoli, T.; Costarelli, L.; Giacconi, R.; Malavolta, M. et al.
    • Year: 2016

  5. Title: The effect of astaxanthin on the aging rat brain: Gender-related differences in modulating inflammation

    • Authors: Balietti, M.; Giannubilo, S.R.; Giorgetti, B.; Solazzi, M.; Turi, A.; Casoli, T.; Ciavattini, A.; Fattoretti, P.
    • Year: 2016

  6. Title: Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration

    • Authors: Casoli, T.; Spazzafumo, L.; Di Stefano, G.; Conti, F.
    • Year: 2015

  7. Title: Effect of cognitive training on the expression of brain-derived neurotrophic factor in lymphocytes of mild cognitive impairment patients

    • Authors: Casoli, T.; Giuli, C.; Balietti, M.; Giorgetti, B.; Solazzi, M.; Fattoretti, P.
    • Year: 2014

  8. Title: One-month strawberry-rich anthocyanin supplementation ameliorates cardiovascular risk, oxidative stress markers and platelet activation in humans

    • Authors: Alvarez-Suarez, J.M.; Giampieri, F.; Tulipani, S.; Casoli, T.; Di Stefano, G.; González-Paramás, A.M.; Santos-Buelga, C.; Busco, F.; Quiles, J.L.; Cordero, M.D. et al.
    • Year: 2014

  9. Title: Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer’s disease

    • Authors: Balietti, M.; Giorgetti, B.; Casoli, T.; Solazzi, M.; Tamagnini, F.; Burattini, C.; Aicardi, G.; Fattoretti, P.
    • Year: 2013

  10. Title: Platelets in Alzheimer’s disease-associated cellular senescence and inflammation

  • Authors: Casoli, T.; Balietti, M.; Giorgetti, B.; Solazzi, M.; Scarpino, O.; Fattoretti, P.
  • Year: 2013
  1. Title: Dynamin binding protein gene expression and memory performance in aged rats
  • Authors: Casoli, T.; Di Stefano, G.; Fattoretti, P.; Giorgetti, B.; Balietti, M.; Lattanzio, F.; Aicardi, G.; Platano, D.
  • Year: 2012

Conclusion 📊

Tiziana Casoli’s career is marked by a deep commitment to understanding the complexities of aging and neurodegenerative diseases. Her contributions to biomarker identification and mitochondrial research have significantly advanced knowledge in the field, while her involvement in numerous high-impact projects showcases her dedication to improving the lives of aging populations. As an active member of SIGG and EPWS, she continues to inspire and collaborate with scientists worldwide.